Alan C. Embry

741 total citations
8 papers, 580 citations indexed

About

Alan C. Embry is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Alan C. Embry has authored 8 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Alan C. Embry's work include Influenza Virus Research Studies (2 papers), RNA Research and Splicing (2 papers) and RNA modifications and cancer (1 paper). Alan C. Embry is often cited by papers focused on Influenza Virus Research Studies (2 papers), RNA Research and Splicing (2 papers) and RNA modifications and cancer (1 paper). Alan C. Embry collaborates with scholars based in United States and Australia. Alan C. Embry's co-authors include Jack R. Bennink, Heather D. Hickman, Jonathan W. Yewdell, Alexandre David, Brian P. Dolan, Kristie M. Grebe, Jeffrey M. Goodenbour, Eva M. Eves, Peter Berglund and Richard B. Jones and has published in prestigious journals such as Nature, The Journal of Immunology and Biochemistry.

In The Last Decade

Alan C. Embry

8 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan C. Embry United States 6 394 101 64 62 53 8 580
Bénédicte Desforges France 17 665 1.7× 90 0.9× 75 1.2× 71 1.1× 59 1.1× 33 948
Daniela Franková Czechia 13 194 0.5× 72 0.7× 87 1.4× 44 0.7× 83 1.6× 33 508
Daesety Vishnuvardhan United States 17 359 0.9× 31 0.3× 74 1.2× 139 2.2× 92 1.7× 29 665
Jorge Torres-Muñoz United States 12 288 0.7× 133 1.3× 91 1.4× 242 3.9× 54 1.0× 19 738
Gérald Gaibelet France 15 389 1.0× 120 1.2× 33 0.5× 26 0.4× 32 0.6× 23 610
Maryline Santerre United States 13 171 0.4× 44 0.4× 60 0.9× 20 0.3× 73 1.4× 19 422
Odell D. Jones United States 11 124 0.3× 61 0.6× 41 0.6× 25 0.4× 40 0.8× 27 343
Molly Sullivan United States 11 139 0.4× 141 1.4× 53 0.8× 28 0.5× 69 1.3× 18 578
Xiaojiao Zheng China 14 296 0.8× 106 1.0× 70 1.1× 66 1.1× 34 0.6× 30 536
Natalia Guerra‐Pérez Spain 11 95 0.2× 130 1.3× 62 1.0× 43 0.7× 28 0.5× 18 367

Countries citing papers authored by Alan C. Embry

Since Specialization
Citations

This map shows the geographic impact of Alan C. Embry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. Embry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. Embry more than expected).

Fields of papers citing papers by Alan C. Embry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. Embry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. Embry. The network helps show where Alan C. Embry may publish in the future.

Co-authorship network of co-authors of Alan C. Embry

This figure shows the co-authorship network connecting the top 25 collaborators of Alan C. Embry. A scholar is included among the top collaborators of Alan C. Embry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan C. Embry. Alan C. Embry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lane, M. Chelsea, Jennifer L. Gordon, Wolfgang W. Leitner, et al.. (2020). Workshop report: Optimization of animal models to better predict influenza vaccine efficacy. Vaccine. 38(13). 2751–2757. 1 indexed citations
2.
Eisinger, Robert W., et al.. (2020). 2019: A Banner Year for Tuberculosis Research. The Journal of Infectious Diseases. 222(11). 1768–1771. 5 indexed citations
3.
Plaeger, Susan, et al.. (2011). Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary. AIDS Research and Human Retroviruses. 28(5). 469–477. 52 indexed citations
4.
Hensley, Scott E., Damien Zanker, Brian P. Dolan, et al.. (2010). Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses. The Journal of Immunology. 184(8). 4115–4122. 85 indexed citations
5.
Grebe, Kristie M., Kazuyo Takeda, Heather D. Hickman, et al.. (2009). Cutting Edge: Sympathetic Nervous System Increases Proinflammatory Cytokines and Exacerbates Influenza A Virus Pathogenesis. The Journal of Immunology. 184(2). 540–544. 100 indexed citations
6.
Netzer, Nikolaus C., Jeffrey M. Goodenbour, Alexandre David, et al.. (2009). Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 462(7272). 522–526. 268 indexed citations
7.
Embry, Alan C., Jennifer L. Glick, Maurine E. Linder, & Patrick J. Casey. (2004). Reciprocal Signaling between the Transcriptional Co-Factor Eya2 and Specific Members of the Gαi Family. Molecular Pharmacology. 66(5). 1325–1331. 28 indexed citations
8.
Bowers, Katherine, et al.. (2003). Kinetic Studies of Protein Farnesyltransferase Mutants Establish Active Substrate Conformation. Biochemistry. 42(32). 9741–9748. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026